How do you lead a company across continents and through uncertainty?

In this episode of A Call to Lead, David Kirk speaks with Samir Ounzain, CEO and scientific co-founder of Haya Therapeutics.

Samir shares how a lifelong curiosity about how cells “speak” to their environment led him from academia to building a company at the frontier of RNA-guided medicine.

He reflects on what it takes to lead through uncertainty, translate visionary science into tangible therapies, and build culture and alignment across continents. This conversation is a masterclass in marrying deep biology with purposeful leadership.